Adult Solid Neoplasm Completed Phase 1 Trials for Selumetinib (DB11689)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029998 (Adult Solid Neoplasm) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01061749 | Selumetinib and Cixutumumab in Treating Patients With Advanced Solid Malignancies | Treatment |